PTSM: Pharmaceutical Technology Sourcing and Management
Metrics Contract Services adopts a more descriptive name and brand that identifies it as being part of the Mayne Pharma global family.
Metrics Contract Services, a contract pharmaceutical formulation development and manufacturing organization, has adopted a new and more descriptive name.
The company is unveiling a new brand look that more clearly identifies Metrics Contract Services as being part of the Mayne Pharma global family, according to a company press release.
“We know from market research that Metrics enjoys a great deal of positive brand equity with clients, who associate us with attributes such as quality, reliability, responsiveness and honesty,” said John S. Ross, executive vice president in the press release. “The new Metrics Contract Services brand identity conveys that we’re the same people, delivering the same quality experiences for clients -- and that now we’re backed by a global pharmaceutical organization with the added resources to deliver even more capabilities.”
With its more descriptive suffix, the name Metrics Contract Services better communicates an ability to deliver a full range of outsourced pharmaceutical formulation development and manufacturing capabilities, Ross said. The new logo--an adaptation of Mayne Pharma’s logo--reflects that Metrics Contract Services is a key component of the global pharmaceutical company, the company reports.
Source: Metrics Contract Services
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.